Afamelanotide (Melanotan I)
Complete Afamelanotide (Melanotan I) Protocol & Tracking Guide
Afamelanotide is the linear analogue of alpha-MSH — FDA/EMA-approved as Scenesse for erythropoietic protoporphyria (EPP). 16mg subcutaneous implant every 60 days.
🔬 Research✨ Free✓ Updated 2026
Overview
Afamelanotide is the linear analogue of alpha-MSH — FDA/EMA-approved as Scenesse for erythropoietic protoporphyria (EPP). 16mg subcutaneous implant every 60 days.
Track with Shotlee
Log your doses, monitor effects, and optimize your protocol with data — completely free.
Get Shotlee Free